Skip to main content

Day: December 5, 2023

Arvinas and Pfizer Announce Interim Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®) and Plans to Expand Vepdegestrant Development Program

– Overall response rate of 42% and median progression-free survival of 11.1 months in heavily pre-treated patients (after 11 months median follow-up time and based on 48% of events) demonstrates the potential of vepdegestrant in combination with palbociclib (IBRANCE®) – – Tolerability generally consistent with the profile of palbociclib and what has been observed in other clinical trials of vepdegestrant– – Pending additional data and agreement with regulatory authorities, Arvinas and Pfizer plan to broaden development of vepdegestrant to include new combinations with CDK inhibitors in both the first- and second-line settings – NEW HAVEN, Conn. and NEW YORK, Dec. 05, 2023 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE: PFE) today announced clinical data for vepdegestrant (ARV-471), a novel oral PROteolysis...

Continue reading

Greif, Inc. Declares Quarterly Dividend

DELAWARE, Ohio, Dec. 05, 2023 (GLOBE NEWSWIRE) — Greif, Inc. (NYSE: GEF, GEF.B), a global leader in industrial packaging products and services, announced today that its Board of Directors has declared quarterly cash dividends of $0.52 per share on its Class A Common Stock, and $0.77 per share on its Class B Common Stock. The dividends are payable on January 1, 2024, to stockholders of record at the close of business on December 18, 2023. About Greif, Inc. Greif is a global leader in industrial packaging products and services and is pursuing its vision: be the best performing customer service company in the world. The Company produces steel, plastic and fibre drums, intermediate bulk containers, reconditioned containers, jerrycans and other small plastics, containerboard, uncoated recycled paperboard, coated recycled paperboard,...

Continue reading

Altamira Therapeutics to Host Investor & Business Update Call on December 11th

HAMILTON, BERMUDA , Dec. 05, 2023 (GLOBE NEWSWIRE) — HAMILTON, BERMUDA–December 5, 2023–Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (Nasdaq: CYTO), a company dedicated to developing therapeutics that address important unmet medical needs, announced today that it will host an Investor and Business Update Call on Monday, December 11, 2023, 8:30 a.m. ET. The presentation will be available via teleconference or webcast with audio and presenter-controlled slides. Webcast Access:Date: Monday, December 11, 2023 Time: 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time) Webcast URL: https://edge.media-server.com/mmc/p/k7s8zdkgRegister for Teleconference:Online registration form:  https://register.vevent.com/register/BIc43c7804270544c6bac8d34949816636  Upon registering you will receive...

Continue reading

Olema Oncology Announces Palazestrant Demonstrates Attractive Combinability with CDK4/6 Inhibitors Ribociclib and Palbociclib in Phase 1b/2 Studies

Palazestrant (OP-1250) in combination with the CDK 4/6 inhibitors, ribociclib and palbociclib, demonstrated no significant drug-drug interaction, no dose-limiting toxicities and a tolerability profile consistent with the FDA-approved labels of ribociclib or palbociclib plus an endocrine therapy OPERA-01 trials-in-progress poster outlines Phase 3 trial design; clinical sites activated and enrolling with first patient dosed in November 2023 Olema will host an investor conference call at 8:00 a.m. ET on December 6, 2023SAN FRANCISCO, Dec. 05, 2023 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology,” Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for women’s cancers, today announced interim results from an ongoing...

Continue reading

American Trust Insurance Joins World Insurance Associates

Iselin, NJ, Dec. 05, 2023 (GLOBE NEWSWIRE) — World Insurance Associates LLC (“World”), a Top 50 Insurance Brokerage, announced today that it acquired the business of American Trust Insurance, LLC (“ATI”) of Huron, SD on December 1, 2023. Terms of the transaction were not disclosed. ATI was founded in 2004, and today it has eight offices within South Dakota. They provide personal and commercial insurance, health and life insurance, and specializes in crop/agricultural/farm insurance. “It’s great to join World Insurance,” says Preston Steele, Principal, American Trust Insurance. “We look forward to offering our clients additional products and services to meet their insurance needs.” “We are very excited about our new partnership with World Insurance,” says Katie Scheuer, Leader, American Trust Insurance. “Our team remains the same,...

Continue reading

Wereldhave acquires shopping center Polderplein in Hoofddorp, the Netherlands, and enters growth phase of its LifeCentral strategy

Wereldhave has reached agreement with DELA Vastgoed B.V. (‘DELA’) regarding the acquisition of shopping center Polderplein and its parking garage in Hoofddorp (The Netherlands), with a total gross lettable area of c17,000 m² (excluding parking). The acquisition perfectly fits within Wereldhave’s strategy and acquisition criteria such as location, value creation opportunities and synergies with the recently delivered Full Service Center Vier Meren. Combined, Vier Meren and Polderplein will create one dominant Full Service Center in the best location of the city, with 49,100 m2 lettable area and 105 shops, with Wereldhave as sole owner. The total purchase price amounts to € 74m (€ 82m including transaction costs), reflecting a net initial yield of 7.6%. As the transaction is 70% equity financed, the loan-to-value will improve by c30bps. Matthijs...

Continue reading

FuelPositive Update: The First On-Farm Green Ammonia System

WATERLOO, Ontario, Dec. 05, 2023 (GLOBE NEWSWIRE) —  FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) (the “Company” or “FuelPositive”) is excited to announce the official delivery date for its first on-farm, containerized, Green Ammonia demonstration system, the FP300. On March 31st2024 the Company anticipates the world’s first, on-demand, modular, Green Ammonia fertilizer and fuel plant to be delivered and operational on the Hiebert’s farm in Manitoba, Canada. The FP300 is destined to become the first farmer-owned Green Ammonia plant in the world. The first system will support optimizing of future versions of this transformative technology. This new approach to farming has the potential of offering reliable supply and cost in addition to eliminating up to 4 tonnes of atmospheric polluting CO2e emissions for every tonne of...

Continue reading

Changes in the Supervisory Board of Admirals Group AS

Admirals Group AS has announced a change to its supervisory board structure. Long-term supervisory board member, Fedor Ragin, will transition to the executive position within Admirals Group. This appointment marks the end of his tenure on the supervisory board, effective December 5, 2023. Mr. Ragin has contributed over five years of service to the Company’s supervisory board, bringing invaluable insights and experience to his new role. The supervisory board of Admirals Group AS will operate as of December 6, 2023 in the following composition: Alexander Tsikhilov, Anton Tikhomirov, Anatolii Mikhalchenko, Dmitri Lauš, Priit Rohumaa. Further information:  Kaia Gil Communication Manager of Admirals Group AS kaia.gil@admiralmarkets.com +372 53 413 764

Continue reading

Sodexo – Monthly disclosure on share capital and voting rights – November 30, 2023

Regulated informationIssy-les-Moulineaux, December 5th, 2023 Monthly disclosure on share capital and voting rightsPursuant to Article L.233-8-II of the French Commercial Code and Article 223-16 of the General Regulations of the Autorités des Marchés Financiers Registered name of the issuer: SODEXO255, quai de la Bataille de Stalingrad – 92130 ISSY-LES-MOULINEAUXDate Total number of shares Actual voting rights * Theoretical voting rights **November 30, 2023147,454,887215,600,248216,678,766* Actual voting rights: all of the Company shares have the same voting rights, except for treasury shares which do not have voting rights and registered shares held for more than four years, which have double voting rights. ** Theoretical voting rights: the number of theoretical voting rights is calculated based on the shares having...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.